Avoidance of perioperative renal toxicity by a modified immunosuppression protocol.
Kormos
R L
RL
Department of Surgery, University of Pittsburgh School of Medicine, PA 15261.
Trento
A
A
Hardesty
R L
RL
Griffith
B P
BP
Thompson
M
M
Bahnson
H T
HT
D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D003404:Creatinine / Q000097:blood; D003524:Cyclosporins / Q000009:adverse effects* / Q000097:blood / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection; D016027:Heart Transplantation / Q000276:immunology / Q000473:pathology* / Q000502:physiology; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D007668:Kidney / Q000187:drug effects / Q000473:pathology*; D008297:Male; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D003524:Cyclosporins; D003404:Creatinine; D001379:Azathioprine